- Home
- SBH vs REPL Comparison
SBH vs REPL Comparison
Compare SBH & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBH
- REPL
- Stock Information
- Founded
- SBH 1964
- REPL 2015
- Country
- SBH United States
- REPL United States
- Employees
- SBH N/A
- REPL 479
- Industry
- SBH Other Specialty Stores
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- SBH Consumer Discretionary
- REPL Health Care
- Exchange
- SBH Nasdaq
- REPL Nasdaq
- Market Cap
- SBH 937.3M
- REPL 757.8M
- IPO Year
- SBH 2006
- REPL 2018
- Fundamental
- Price
- SBH $8.69
- REPL $9.27
- Analyst Decision
- SBH Buy
- REPL Strong Buy
- Analyst Count
- SBH 6
- REPL 7
- Target Price
- SBH $12.70
- REPL $20.83
- AVG Volume (30 Days)
- SBH 1.6M
- REPL 1.3M
- Earning Date
- SBH 08-07-2025
- REPL 08-07-2025
- Dividend Yield
- SBH N/A
- REPL N/A
- EPS Growth
- SBH 18.05
- REPL N/A
- EPS
- SBH 1.76
- REPL N/A
- Revenue
- SBH $3,698,409,000.00
- REPL N/A
- Revenue This Year
- SBH N/A
- REPL N/A
- Revenue Next Year
- SBH $1.40
- REPL N/A
- P/E Ratio
- SBH $4.94
- REPL N/A
- Revenue Growth
- SBH 0.17
- REPL N/A
- 52 Week Low
- SBH $7.54
- REPL $6.44
- 52 Week High
- SBH $14.79
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- SBH 48.55
- REPL 49.26
- Support Level
- SBH $8.45
- REPL $9.50
- Resistance Level
- SBH $9.37
- REPL $10.09
- Average True Range (ATR)
- SBH 0.30
- REPL 0.60
- MACD
- SBH -0.06
- REPL -0.06
- Stochastic Oscillator
- SBH 25.54
- REPL 9.76
About SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. Sally Beauty operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, and the Netherlands. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. Product offerings include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.